Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Mgmt Meeting Takeaways: FDA Desire to Use 505(j) for M356
Go back to Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Mgmt Meeting Takeaways: FDA Desire to Use 505(j) for M356| Baxter International Inc. (NYSE: BAX) | Delayed: 26.34 -0.07 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.41 | 52 Week High | $50.16 | |||
| Open | $26.51 | 52 Week Low | $34.06 | |||
| Day High | $26.67 | P/E | 7.20 | |||
| Day Low | $26.09 | EPS | $3.66 | |||
| Volume | 4,360,830 | |||||
| Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) | Delayed: 52.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.48 | 52 Week High | $18.32 | |||
| Open | $39.17 | 52 Week Low | $7.86 | |||
| Day High | $52.48 | P/E | N/A | |||
| Day Low | $52.48 | EPS | $-2.13 | |||
| Volume | 147,551 | |||||
